Goodman Corey S - Net Worth and Insider Trading

Goodman Corey S Net Worth

The estimated net worth of Goodman Corey S is at least $15 Million dollars as of 2024-11-05. Goodman Corey S is the Executive Chairman of ALX Oncology Holdings Inc and owns about 9,867,295 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $15 Million. Details can be seen in Goodman Corey S's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Goodman Corey S has not made any transactions after 2020-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Goodman Corey S

Goodman Corey S Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Goodman Corey S owns 10 companies in total, including Metacrine Inc (MTCR) , Checkmate Pharmaceuticals Inc (CMPI) , and ALX Oncology Holdings Inc (ALXO) among others .

Click here to see the complete history of Goodman Corey S’s form 4 insider trades.

Insider Ownership Summary of Goodman Corey S

Ticker	Comapny	Transaction Date	Type of Owner
MTCR	Metacrine Inc	2020-09-18	10 percent owner & other: See Remarks
CMPI	Checkmate Pharmaceuticals Inc	2020-08-06	10 percent owner
ALXO	ALX Oncology Holdings Inc	2020-07-21	director & 10 percent owner & other: Executive Chairman
		2020-07-01	10 percent owner
		2019-03-27	10 percent owner
		2007-10-04	Senior Vice President
		2021-04-22	10 percent owner
		2022-05-25	10 percent owner
		2021-10-20	10 percent owner & other: See Remarks
		2023-09-14	10 percent owner

Goodman Corey S Latest Holdings Summary

Goodman Corey S currently owns a total of 1 stock. Goodman Corey S owns 9,867,295 shares of ALX Oncology Holdings Inc (ALXO) as of July 21, 2020, with a value of $15 Million.

Latest Holdings of Goodman Corey S

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ALXO	ALX Oncology Holdings Inc	2020-07-21	9,867,295	1.52	14,998,288

Holding Weightings of Goodman Corey S

Goodman Corey S Form 4 Trading Tracker

According to the SEC Form 4 filings, Goodman Corey S has made a total of 1 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 850,000 shares on July 21, 2020, which cost Goodman Corey S around $16 Million.

Insider Trading History of Goodman Corey S

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Goodman Corey S Trading Performance

GuruFocus tracks the stock performance after each of Goodman Corey S's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goodman Corey S is 38.74%. GuruFocus also compares Goodman Corey S's trading performance to market benchmark return within the same time period. The performance of stocks bought by Goodman Corey S within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Goodman Corey S's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Goodman Corey S

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	46.47
Relative Return to S&P 500(%)	42.18

Goodman Corey S Ownership Network

Ownership Network List of Goodman Corey S

No Data

Ownership Network Relation of Goodman Corey S

Goodman Corey S Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Goodman Corey S is the 10 percent owner & other: See Remarks of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metacrine Inc Insider Transactions

No Available Data

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Goodman Corey S is the 10 percent owner of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Goodman Corey S is the director & 10 percent owner & other: Executive Chairman of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .

In summary, during the past 3 months, insiders sold 3,866 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 3,866 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ALX Oncology Holdings Inc Insider Transactions

No Available Data

What does Akero Therapeutics Inc do?

Who are the key executives at Akero Therapeutics Inc?

Goodman Corey S is the 10 percent owner of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include director & President & CEO Andrew Cheng , Chief Development Officer Catriona Yale , and Chief Operating Officer Jonathan Young .

Akero Therapeutics Inc (AKRO) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 171,998 shares made by Jonathan Young , a net sale of 443,502 shares made by Andrew Cheng , and a net sale of 140,584 shares made by Catriona Yale .

In summary, during the past 3 months, insiders sold 478,023 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 478,023 shares. During the past 18 months, 1,227,763 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 92,237 shares.

Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akero Therapeutics Inc Insider Transactions

No Available Data

What does Precision BioSciences Inc do?

Who are the key executives at Precision BioSciences Inc?

Goodman Corey S is the 10 percent owner of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include General Counsel Dario Scimeca , 10 percent owner J. Jefferson Smith , and Chief Medical Officer Alan List .

Precision BioSciences Inc (DTIL) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 51,036 shares made by Dario Scimeca , a net sale of 263,941 shares made by Michael Amoroso , and a net sale of 28,204 shares made by J. Jefferson Smith .

In summary, during the past 3 months, insiders sold 0 shares of Precision BioSciences Inc (DTIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,710 shares of Precision BioSciences Inc (DTIL) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 11,710 shares.

Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precision BioSciences Inc Insider Transactions

No Available Data

What does Pfizer Inc do?

Who are the key executives at Pfizer Inc?

Goodman Corey S is the Senior Vice President of Pfizer Inc. Other key executives at Pfizer Inc include SVP & Controller Jennifer B. Damico , Executive Vice President Christoffel Boshoff , and Executive Vice President Payal Sahni .

Pfizer Inc (PFE) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in Pfizer Inc (PFE). Other recent insider transactions involving Pfizer Inc (PFE) include a net purchase of 6,000 shares made by Scott Gottlieb , and a net sale of 5,154 shares made by Jennifer B. Damico .

In summary, during the past 3 months, insiders sold 5,154 shares of Pfizer Inc (PFE) in total and bought 1,000 shares, with a net sale of 4,154 shares. During the past 18 months, 5,154 shares of Pfizer Inc (PFE) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 846 shares.

Pfizer Inc (PFE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pfizer Inc Insider Transactions

No Available Data

What does IPI Legacy Liquidation Co do?

Who are the key executives at IPI Legacy Liquidation Co?

Goodman Corey S is the 10 percent owner of IPI Legacy Liquidation Co. Other key executives at IPI Legacy Liquidation Co include 10 percent owner Vivo Capital Fund Viii, L.p. , CFO Michael Wayne Kalb , and VP & Controller & Interim CFO Rajiv Amin .

IPI Legacy Liquidation Co (IMPLQ) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in IPI Legacy Liquidation Co (IMPLQ). Other recent insider transactions involving IPI Legacy Liquidation Co (IMPLQ) include a net sale of 575,000 shares made by Vivo Capital Fund Viii, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of IPI Legacy Liquidation Co (IMPLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 575,000 shares of IPI Legacy Liquidation Co (IMPLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 575,000 shares.

IPI Legacy Liquidation Co (IMPLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IPI Legacy Liquidation Co Insider Transactions

No Available Data

What does Elevation Oncology Inc do?

Who are the key executives at Elevation Oncology Inc?

Goodman Corey S is the 10 percent owner of Elevation Oncology Inc. Other key executives at Elevation Oncology Inc include CHIEF FINANCIAL OFFICER Tammy Furlong , 10 percent owner Venbio Global Strategic Gp Iii, L.p. , and 10 percent owner Venbio Global Strategic Fund Iii, L.p. .

Elevation Oncology Inc (ELEV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elevation Oncology Inc Insider Transactions

No Available Data

What does Ventyx Biosciences Inc do?

Who are the key executives at Ventyx Biosciences Inc?

Goodman Corey S is the 10 percent owner & other: See Remarks of Ventyx Biosciences Inc. Other key executives at Ventyx Biosciences Inc include director & Chief Executive Officer Raju Mohan , Chief Financial Officer Martin Auster , and Chief Scientific Officer John Nuss .

Ventyx Biosciences Inc (VTYX) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in Ventyx Biosciences Inc (VTYX). Other recent insider transactions involving Ventyx Biosciences Inc (VTYX) include a net sale of 573,232 shares made by Nsv Partners Iii Lp , a net sale of 573,232 shares made by Somu Subramaniam , and a net sale of 71,074 shares made by William J. Sandborn .

In summary, during the past 3 months, insiders sold 0 shares of Ventyx Biosciences Inc (VTYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,675,810 shares of Ventyx Biosciences Inc (VTYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,675,810 shares.

Ventyx Biosciences Inc (VTYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ventyx Biosciences Inc Insider Transactions

No Available Data

What does RayzeBio inc do?

Who are the key executives at RayzeBio inc?

Goodman Corey S is the 10 percent owner of RayzeBio inc. Other key executives at RayzeBio inc include 10 percent owner Viking Global Investors Lp , 10 percent owner Viking Global Opportunities Parent Gp Llc , and 10 percent owner Viking Global Opportunities Drawdown (aggregator) Lp .

RayzeBio inc (RYZB) Insider Trades Summary

Over the past 18 months, Goodman Corey S made no insider transaction in RayzeBio inc (RYZB). Other recent insider transactions involving RayzeBio inc (RYZB) include a net purchase of 2,777,778 shares made by Viking Global Investors Lp , and a net purchase of 472,222 shares made by Maha Katabi .

In summary, during the past 3 months, insiders sold 0 shares of RayzeBio inc (RYZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RayzeBio inc (RYZB) were sold and 3,250,000 shares were bought by its insiders, resulting in a net purchase of 3,250,000 shares.

RayzeBio inc (RYZB)'s detailed insider trading history can be found in Insider Trading Tracker table.

RayzeBio inc Insider Transactions

No Available Data

Goodman Corey S Mailing Address

Above is the net worth, insider trading, and ownership report for Goodman Corey S. You might contact Goodman Corey S via mailing address: 1700 Owens Street, Suite 595, San Francisco Ca 94158.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.